We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
Broadcasting legend and Parkinson's UK celebrity ambassador David 'Kid' Jensen is taking part in a world-first clinical trial. The trial will help researchers understand if an anti-sickness drug could treat hallucinations in people with Parkinson's or Lewy body dementia.
Date
A change to the law in England, Scotland and Wales means a wider range of healthcare professionals can now assess fitness to drive. We hope this will speed up people being able to get their driving licences.
Date
An important research partnership involving Parkinson's UK, pharmaceutical company UCB and the Parkinson's Foundation has published their first results in a study designed alongside people living with Parkinson's.
Date
National Co-production Week 2022 runs from 4 to 9 July and is back for a 7th year. We look to the future of co-production at Parkinson's UK.
Date
Campaigners share their work and plan activities to improve Parkinson's care
Date
News on changes to the healthcare professionals who can issue fit to work notes from 1 July 2022 in England, Scotland and Wales.
Date
An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson's.
Date
We're calling on the Parkinson's community to take part in 5 important clinical studies that are currently at risk of closure.
Date
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Date
Research led by Cambridge University and part funded by Parkinson's UK shows that a form of brain scan could help identify those at risk of specific Parkinson's symptoms.